Beta

Spending
Congress
Stocks
Lobbying

Spending
Congress
Stocks
Lobbying

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Congress
Stocks
Lobbying

OWLET — Lobbying — Receipts Report

LD-2 disclosure · 4th Quarter - Report

OWLET

via THE MCMANUS GROUP

4th Quarter (Oct 1 - Dec 31) · 2025Posted Jan 20, 2026Filing document ↗LDA record ↗

Income$40Kfee reported

Client

Name: OWLET
Description: Medical Device
Location: Utah · United States of America

Registrant

Firm: THE MCMANUS GROUP
Description: Consulting
Location: Washington, District of Columbia, United States of America

Lobbying activities

1 issue

Health Issues
H.R. 2168, Baby Observation (BO's) Act
LobbyistsJOHN MCMANUS · ABIGAIL SMITH · ms MARY GRACE DARCEY
TargetedSENATE · HOUSE OF REPRESENTATIVES

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.